Enjoy complimentary customisation on priority with our Enterprise License!
The preeclampsia laboratory testing market is estimated to grow at a CAGR of 8% between 2022 and 2027. The size of the market is forecasted to increase by USD 785.73 million. The growth of the market depends on several factors, including market expansion in emerging economies, the increasing incidence of preterm births, and the rising number of gynecology clinics.
This report extensively covers market segmentation by product type (consumables and instruments), test (blood test, urine test, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download Report Sample
The increasing incidence of preterm births is notably driving the market growth, although factors such as lack of reimbursement may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Preeclampsia Laboratory Testing Market Driver
Significant Preeclampsia Laboratory Testing Market Trend
Major Preeclampsia Laboratory Testing Market Challenge
Public and private insurers do not reimburse for preeclampsia laboratory testing.
Pregnant women are eligible for Medicaid but can lose coverage at sixty days postpartum, which makes them unable to afford preeclampsia laboratory testing.
Key Preeclampsia Laboratory Testing Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Preeclampsia Laboratory Testing Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - The company offers preeclampsia laboratory testing such as i-STAT TOTAL beta-hCG CARTRIDGE.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the consumables segment will be significant during the forecast period. Consumables are necessary for the selection and enrichment of preeclampsia laboratory testing procedures. Reagents are chemical substances or mixtures that are used during preeclampsia laboratory procedures. Factors such as the low cost and high usage frequency of consumables are driving the growth of the consumables segment.
Get a glance at the market contribution of various segments Request a PDF Sample
The consumables segment was valued at USD 867.00 million in 2017 and continue to grow until 2021. The consumables segment is likely to grow at a rapid pace during the forecast period. Many suppliers are investing in reagents and consumables, as they generate a high return on investment (ROI). Many government organizations such as the National Institute of Health (NIH) offer grants for the quarterly reimbursements of R&D of consumables. Therefore, the use of reagents and consumables will increase due to the rise in the number of point-of-care testing in hospitals, clinics, and homes and the growth of online purchases.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The US is the leading country in the market in North America. The growth of the market in this country is attributed to factors such as the rising focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several vendors. In Canada, the increasing awareness about maternal and fetal healthcare through the Canadian Fetal Health Surveillance Program and the Canadian Premature Babies Foundation (CPBF) has led to the rapid adoption of preeclampsia laboratory testing products in maternity clinical settings. In Mexico, increasing government and private hospital budgets, a growing number of hospitals and maternity centers, a high neonatal mortality rate, and the growing demand for high-tech pregnancy screening devices and maternity care facilities are driving the growth of the preeclampsia laboratory testing market in the country.
This report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. The outbreak of COVID-19 in 2020 led to industry closures. Due to the medical community's focus on treating COVID-19, the funding for R&D related to preeclampsia laboratory testing products was reduced. This hindered the growth of the regional market. However, in 2021, owing to the initiation of vaccination drives, the regional market started to recover, and it is expected to witness growth during the forecast period.
The report forecasts market growth by revenue at global, regional, and country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
The reports categorize the global preeclampsia laboratory testing market as a part of the life sciences tools & services, which covers products and companies engaged in R&D of a variety of product categories, including capital equipment, instruments, accessories, and consumables. It also covers life sciences-related services, including contract research, contract manufacturing, and contract sales. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.
Preeclampsia Laboratory Testing Market Scope |
|
Report Coverage |
Details |
Page number |
162 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8% |
Market growth 2023-2027 |
USD 785.73 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
7.45 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, Germany, UK, China, and India |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, ACON Laboratories Inc., Bio Rad Laboratories Inc., BioCheck Inc., bioMerieux SA, Biora Therapeutics Inc., Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., GestVision Inc., Lifeassay Diagnostics Pty Ltd., MedGyn Products Inc., Metabolomic Diagnostics, MOMM Diagnostics, Perkin Elmer Inc., Quidel Corp., Sera Prognostics Inc., Siemens AG, Thermo Fisher Scientific Inc., and Avecon Healthcare Pvt. Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Market Segmentation by Test
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.